UT Health San Antonio-led discovery means IV medication could be taken orally for range of cancer, Alzheimer’s treatments
April 22, 2025
Major breakthrough could redefine drug discovery, broaden options A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs in …
Magnesium channel key to immune cell shift offers new hope for oral cancer prevention, treatment
April 21, 2025
The ability of macrophages, a type of white blood cell, to transition into one of two forms, is critical for immune system functionality. These cells can morph into fighter cells (M1) that cause inflammation and attack invading pathogens, or nurse cell …
UT Health San Antonio scientists pioneer drug-discovery breakthrough for large and polar drugs
April 18, 2025
iStock Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal …
Breast cancer research with global impact
April 2, 2025
BRCA1 and BRCA2 are genes that help protect the body by fixing damaged DNA and keeping cells healthy. When these genes have changes, or mutations, they don’t work the way they should. This can raise the risk of certain cancers, like breast, ovarian, prostate and pancreatic cancer. These inherited mutations affect about 1 in every 200 to 300 people — over a million in the U.S. alone.
UT Health San Antonio-led research discovers a way to slow or block recurrence of glioblastoma
March 26, 2025
Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation, bringing new hope for survival.
Promising cancer researcher, Falzone, receives UT System Rising STARs award
March 25, 2025
Maria E. Falzone, PhD Maria E. Falzone, PhD, assistant professor in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health …
UT Health San Antonio develops drug found to more than double survival time for glioblastoma patients
March 7, 2025
New hope for adult sufferers of most common primary brain tumor A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common p …
Targeted drug offers hope for safe, effective senolytic treatment for liver disease, cancer
March 3, 2025
San Antonio has one of the highest rates of metabolic dysfunction-associated steatotic liver disease (MASLD) in the United States, largely driven by high rates of obesity and diabetes in the region. This chronic liver condition can lead to serious heal …
CPRIT awards UT Health San Antonio $3.2 million to accelerate cancer research, launch novel clinical trial
February 27, 2025
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received more than $3.19 million in new academic research awards as part of the latest $68 million funding round announced on February 19 by the Cancer Research …
Cracking cancer’s code: New research identifies novel drug target for acute myeloid leukemia treatment
February 21, 2025
Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors in the development of AML are diverse with many different drivers. A longtime goal for scientists in this field is finding a single drug that can treat all types of AML.